Newsroom

In 2014, Temple University researchers proved they could use state-of-the-art molecular scissors to cut out dormant HIV hiding in human cells in lab dishes. Now, seven years later — the blink of an eye in basic research — the approach has received Food and Drug Administration approval for testing in humans, buoying hopes for curing, not just suppressing, the insidious virus that causes AIDS. Although the world is focused on the COVID-19 pandemic, HIV/AIDS continues to rage in many poor countries 40 years after it was identified.

Maura Sammon, MD, Associate Professor of Clinical Emergency Medicine, spoke with CBS3 about helping care for Afghan evacuees who have arrived at Philadelphia International Airport. The evacuees undergo medical screenings, COVID testing and urgent care treatment if necessary.

Joice Kanefsky, 28, is beginning her fourth year as a PhD student in the Biomedical Sciences Graduate Program at Temple University’s Lewis Katz School of Medicine. She is a native of the state of Minas Gerais in Brazil and a graduate of Universidade Federal de Minas Gerais. As president of the Graduate Student Association, she organized the Dawn Marks Research Day that was held on Friday, August 27, at Temple’s Medical Education and Research Building. Thirty-five MS, PhD, and MD/PhD students displayed posters or made oral presentations describing their research findings. Everyone from the medical school was invited to attend.